Novartis AG ADR Cash Flow-to-Debt Ratio
Novartis AG ADR cash flow-to-debt ratio. Novartis AG ADR (NVS) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2026, meaning its operating cash flow of $5.89 Billion could theoretically repay 0% of its total liabilities ($80.09 Billion) in one year. Check Novartis AG ADR earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Novartis AG ADR (1998–2025)
Cash flow-to-debt ratio of Novartis AG ADR from 1998 to 2025. Historical debt coverage capacity for Novartis AG ADR across 28 annual periods. Check NVS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Novartis AG ADR Cash Flow-to-Debt Ratio by Year (1998–2025)
Novartis AG ADR cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Novartis AG ADR. For the full cash flow conversion analysis, see Novartis AG ADR operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | $19.24 Billion | $69.02 Billion | ▼ -8.0% |
| 2024 | 0.30x | $17.62 Billion | $58.12 Billion | ▲ +11.5% |
| 2023 | 0.27x | $14.46 Billion | $53.20 Billion | ▲ +10.8% |
| 2022 | 0.25x | $14.24 Billion | $58.03 Billion | ▲ +4.1% |
| 2021 | 0.24x | $15.07 Billion | $63.97 Billion | ▲ +30.3% |
| 2020 | 0.18x | $13.65 Billion | $75.52 Billion | ▼ -16.6% |
| 2019 | 0.22x | $13.62 Billion | $62.86 Billion | ▲ +1.6% |
| 2018 | 0.21x | $14.27 Billion | $66.87 Billion | ▼ -0.5% |
| 2017 | 0.21x | $12.62 Billion | $58.85 Billion | ▲ +3.2% |
| 2016 | 0.21x | $11.47 Billion | $55.23 Billion | ▼ -4.9% |
| 2015 | 0.22x | $11.90 Billion | $54.43 Billion | ▼ -14.2% |
| 2014 | 0.25x | $13.90 Billion | $54.54 Billion | ▲ +0.1% |
| 2013 | 0.25x | $13.17 Billion | $51.78 Billion | ▼ -1.4% |
| 2012 | 0.26x | $14.19 Billion | $55.00 Billion | ▼ -7.0% |
| 2011 | 0.28x | $14.31 Billion | $51.56 Billion | ▲ +5.7% |
| 2010 | 0.26x | $14.07 Billion | $53.55 Billion | ▼ -18.0% |
| 2009 | 0.32x | $12.19 Billion | $38.04 Billion | ▼ -8.6% |
| 2008 | 0.35x | $9.77 Billion | $27.86 Billion | ▼ -0.8% |
| 2007 | 0.35x | $9.21 Billion | $26.06 Billion | ▲ +8.4% |
| 2006 | 0.33x | $8.71 Billion | $26.71 Billion | ▼ -0.9% |
| 2005 | 0.33x | $8.08 Billion | $24.57 Billion | ▲ +0.5% |
| 2004 | 0.33x | $6.72 Billion | $20.55 Billion | ▼ -7.5% |
| 2003 | 0.35x | $6.65 Billion | $18.80 Billion | ▲ +1.6% |
| 2002 | 0.35x | $5.83 Billion | $16.73 Billion | ▲ +15.9% |
| 2001 | 0.30x | $4.43 Billion | $14.75 Billion | ▼ -16.1% |
| 2000 | 0.36x | $4.64 Billion | $12.96 Billion | ▲ +45.9% |
| 1999 | 0.25x | $4.33 Billion | $17.67 Billion | ▲ +0.7% |
| 1998 | 0.24x | $4.28 Billion | $17.56 Billion | — |